According to ChemAnalyst, The Pantoprazole Sodium Prices witnessed a notable upward trajectory during the first quarter of 2026, supported by rising production costs, increasing feedstock prices, stable pharmaceutical demand, and persistent supply chain constraints across major global markets. Pantoprazole Sodium, a proton pump inhibitor (PPI) extensively prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and aci
